Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 2/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 5/20 | 0.36 |
| ▸ | CA1 | P00915 | 5/20 | 0.36 |
| ▸ | CA2 | P00918 | 5/20 | 0.36 |
| ▸ | CA4 | P22748 | 5/20 | 0.36 |
| ▸ | CA9 | Q16790 | 5/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.34 |
| ▸ | PPARD | Q03181 | 2/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3402232 | 0.93 | LPAR1 (0.39) | LPAR1LPAR2CA12CA1CA2 | |
| SCHEMBL3433506 | 0.89 | LPAR1 (0.35) | LPAR1LPAR2CA12CA1CA2 | |
| SCHEMBL18628115 | 0.82 | LPAR1 (0.37) | LPAR1LPAR2CA12CA1CA2 | |
| SCHEMBL3433166 | 0.80 | LPAR1 (0.31) | LPAR1LPAR2 | |
| SCHEMBL8548578 | 0.73 | CTSA (0.45) | — | |
| SCHEMBL10535744 | 0.66 | GFER (0.41) | CA12CA1CA2CA4CA9 | |
| SCHEMBL18677954 | 0.64 | PDK2 (0.34) | LPAR1CA12CA1CA2CA4 | |
| SCHEMBL10515719 | 0.62 | ADORA2B (0.46) | L3MBTL1ADORA2BPTGDR2 | |
| SCHEMBL3477183 | 0.62 | NR1D1 (0.34) | L3MBTL1 | |
| SCHEMBL9356014 | 0.61 | GFER (0.38) | CA12CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104884392-A | method for ore separation | GEORGIA PACIFIC CHEMICALS LLC | 2015-09-02 | — | — | CN | disclosed |
| WO-2014066237-A1 | PROCESSES FOR THE SEPARATION OF ORES | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2014-05-01 | — | — | WO | disclosed |
| US-8252866-B2 | Azetidinium-functional polysaccharides and uses thereof | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2012-08-28 | — | — | US | disclosed |
| US-20100294725-A1 | AZETIDINIUM-FUNCTIONAL POLYSACCHARIDES AND USES THEREOF | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2010-11-25 | — | — | US | disclosed |
| EP-2052252-B1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | ABACUS DIAGNOSTICA OY (FI) | 2010-11-10 | — | — | EP | disclosed |
| US-20100215685-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | OM PHARMA (CH) | 2010-08-26 | — | — | US | disclosed |
| US-7781501-B2 | Thermosetting adhesives comprising a resin having azetidinium functional groups | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2010-08-24 | — | — | US | disclosed |
| US-20070054144-A1 | THERMOSETTING ADHESIVES COMPRISING A RESIN HAVING AZETIDINIUM FUNCTIONAL GROUPS | GEORGIA-PACIFIC RESINS, INC. (US) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215685-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | PIGS, DNPEP, ENPP2 | LPAR1 1303/4885LPAR2 750/4885CA12 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.